BioSense 2.0 final evaluation plan
Published Date:April 2013
Corporate Authors:RTI International. ; Centers for Disease Control and Prevention (U.S.). Office of Surveillance, Epidemiology and Laboratory Services. Public Health Surveillance and Informatics Program Office. Division of Notifiable Diseases and Healthcare Information. ;
Description:In 2003 the Centers for Disease Control and Prevention (CDC) launched BioSense 1.0 as a nationwide integrated system for early detection and assessment of bioterrorism-related illness that would receive automated data feeds from hospitals and medical facilities operated by the U.S. Department of Veterans Affairs (VA) and Department of Defense (DoD). In the years that followed, BioSense 1.0 added syndromic data from state health departments, anti-infective prescription data, and laboratory data from selected vendors. In June 2010 a 4-year effort, the BioSense Redesign project, was initiated to transform BioSense 1.0 to BioSense 2.0—an all-hazards surveillance system that would provide multipurpose value and timely data for regional and national public health situation awareness, routine public health practice, and health outcomes and public health improvement.
Drawing upon 8 years of programmatic experience, stakeholder meetings, U.S. Senate’s input, General Accounting Office (GAO) reports, and a year of intensive user requirements gathering, the redesigned BioSense 2.0 aims to:
• Incorporate state and local public health partners’ input into the BioSense Program design and governance.
• Promote a proactive, collaborative, and transparent community.
• Support the transmittal of syndromic surveillance data to meet Meaningful Use requirements.
• Support an open, distributed computing model.
• Improve the utility of the data/data sources.
• Facilitate real-time interjurisdictional communication and collaboration.
• Promote innovative epidemiological methods and practices.
• Enhance the capacity of the public health workforce for surveillance practice.
BioSense 2.0 represents a significant realignment of structure and governance from the previous system. Now in its third year, the BioSense Redesign has focused on coordinating efforts across multiple stakeholders [CDC, Association of State and Territorial Health Officers (ASTHO), National Association of County and City Health Officials (NACCHO), Council of State and Territorial Epidemiologists (CSTE)], and the International Society for Disease Surveillance (ISDS), enhancing program visibility and recognition, building local capacity through training and technical assistance, and supporting the expansion of BioSense 2.0 through targeted recruitment and onboarding activities. The BioSense Redesign effort now requires a formative evaluation to ensure it is on track to achieve BioSense 2.0 aims.
RTI Project Number 0212633.002.002
Supporting Files:No Additional Files
You May Also Like: